Acción KK3A CYTOKINETICS, INCORPORATED
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Cytokinetics, Incorporated Deutsche Boerse AG

Acciones

KK3A

US23282W6057

Mercado cerrado - Deutsche Boerse AG
Otros sitios de cotización
 21:41:05 28/06/2024 		Varia. Cinco días. Varia. 1 de enero.
49,4 EUR -0,80 % Gráfico intradía de Cytokinetics, Incorporated +2,92 % -33,24 %
17/06 Insider de Cytokinetics vendió acciones por valor de 262.750 dólares, según un reciente registro de la SEC MT
17/06 Un insider de Cytokinetics vendió acciones por valor de 1.183.391 dólares, según un reciente registro de la SEC MT

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
Cytokinetics Insider Sold Shares Worth $262,750, According to a Recent SEC Filing
Cytokinetics Insider Sold Shares Worth $1,183,391, According to a Recent SEC Filing
Cytokinetics Announces Initiation of Phase 1 Study of Aficamten in Healthy Japanese Participants
Cytokinetics Announces Initiation of Phase 1 Study of Aficamten in Healthy Japanese Participants
Cytokinetics Insider Sold Shares Worth $413,106, According to a Recent SEC Filing
Cytokinetics Insider Sold Shares Worth $1,099,125, According to a Recent SEC Filing
Sector Update: Health Care Stocks Advance Late Afternoon
Sector Update: Health Care Stocks Rise Wednesday Afternoon
Sector Update: Health Care
Cytokinetics Says Third Party Dropped Takeover Bid Despite Negotiations; Shares Rise
Cytokinetics CEO Says Board Would Have Backed Actionable Buyout
Cytokinetics Incorporated : Regulation FD Presentation Form 8 K
Cytokinetics Says Third Party Did Not Move Forward with Acquisition After Talks
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cytokinetics Insider Sold Shares Worth $635,978, According to a Recent SEC Filing
Cytokinetics to Participate in June Investor Conferences
Cytokinetics Closes $500 Million Stock Offering
Cytokinetics Announces Closing of Public Offering of Common Stock
Cytokinetics, Incorporated announced that it has received $49.999992 million in funding from Royalty Pharma Development Funding, LLC
Sector Update: Health Care Stocks Flat to Lower Premarket Thursday
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción CYTK
  4. Acción KK3A
  5. Noticias Cytokinetics, Incorporated
  6. Otros idiomas